About the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. Session
Gender-specific cancers require tailored research to address the unique needs of men and women. Gynecologic cancers, including cervical, ovarian, and uterine cancers, benefit from advancements in HPV vaccines, minimally invasive surgeries, and targeted therapies. Prostate cancer research focuses on improving outcomes through advanced imaging, androgen deprivation therapy, and precision medicine approaches. Gender-based differences in cancer biology, treatment responses, and survivorship experiences are integral to developing effective strategies. Collaborative studies and patient-centered care models aim to enhance treatment efficacy while addressing quality-of-life concerns.
Topics Covered in Gender-Specific Cancers: Gynecologic cancers, Prostate cancer.
Cervical Cancer & HPV
Ovarian Cancer Genomics
Uterine Cancer
Prostate Cancer Imaging
Androgen Signaling
Sex-Based Differences
Related Scientific Sessions at CIOC 2027
Why Attend the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. Conference 2027 — FAQs
What is the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. track at CIOC 2027?
The Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gender-Specific Cancers: Gynecologic cancers, Prostate cancer.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. sessions?
Cancer researchers and clinicians, educators and students with an interest in Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. are all welcome — whether presenting or attending.
Can I present my research in the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gender-Specific Cancers: Gynecologic cancers, Prostate cancer. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.